XML 31 R17.htm IDEA: XBRL DOCUMENT
v3.23.3

Financial Instruments | 9 Months Ended
--- | ---
Oct. 01, 2023
Fair Value Disclosures [Abstract] |
Financial Instruments | F. FINANCIAL INSTRUMENTS Cash Equivalents Teradyne considers all highly liquid investments with maturities of three months or less at the date of acquisition to be cash equivalents. Marketable Securities Teradyne’s equity and debt mutual funds are classified as Level 1 and available-for-sale debt securities are classified as Level 2. Contingent consideration is classified as Level 3. The vast majority of Level 2 securities are fixed income securities priced by third party pricing vendors. These pricing vendors utilize the most recent observable market information in pricing these securities or, if specific prices are not available, use other observable inputs like market transactions involving identical or comparable securities. During the three and nine months ended October 1, 2023 and October 2, 2022, there were no transfers in or out of Level 1, Level 2, or Level 3 financial instruments. Realized gains recorded in the three and nine months ended October 1, 2023, were $0.1 million and $0.6 million, respectively. Realized gains recorded in the three and nine months ended October 2, 2022, were $0.1 million and $0.6 million, respectively. No realized losses were recorded in the three months ended October 1, 2023. Realized losses recorded in the nine months ended October 1, 2023, were $0.3 million. Realized losses recorded in the three and nine months ended October 2, 2022, were $0.3 million and $0.9 million, respectively. Realized gains and losses are included in other (income) expense, net. No unrealized gains on equity securities were recorded in the three months ended October 1, 2023. Unrealized gains on equity securities recorded in the nine months ended October 1, 2023 were $4.6 million. No unrealized gains on equity securities were recorded in the three and nine months ended October 2, 2022. Unrealized losses on equity securities were recorded in the three and nine months ended October 1, 2023 were $1.7 million. Unrealized losses on equity securities recorded in the three and nine months ended October 2, 2022, were $2.3 million and $11.1 million, respectively. Unrealized gains and losses on equity securities are included in other (income) expense, net. Unrealized gains and losses on available-for-sale debt securities are included in accumulated other comprehensive income (loss) on the balance sheet. The cost of securities sold is based on average cost. The following table sets forth by fair value hierarchy Teradyne’s financial assets and liabilities that were measured at fair value on a recurring basis as of October 1, 2023 and December 31, 2022.
|  | October 1, 2023 |
|  | Quoted Prices in Active Markets for Identical Instruments (Level 1) |  |  | Significant Other Observable Inputs (Level 2) |  |  | Significant Unobservable Inputs (Level 3) |  |  | Total |
|  | (in thousands) |
Assets |  |  |  |  |  |  |  |  |  |  |  |
Cash |  | $ | 309,348 |  |  | $ | — |  |  | $ | — |  |  | $ | 309,348 |
Cash equivalents |  |  | 307,160 |  |  |  | 20,453 |  |  |  | — |  |  |  | 327,613 |
Available-for-sale securities: |  |  |  |  |  |  |  |  |  |  |  |
U.S. Treasury securities |  |  | — |  |  |  | 58,499 |  |  |  | — |  |  |  | 58,499 |
Corporate debt securities |  |  | — |  |  |  | 50,830 |  |  |  | — |  |  |  | 50,830 |
Commercial paper |  |  | — |  |  |  | 12,454 |  |  |  | — |  |  |  | 12,454 |
Debt mutual funds |  |  | 8,236 |  |  |  | — |  |  |  | — |  |  |  | 8,236 |
Certificates of deposit and time deposits |  |  | — |  |  |  | 6,688 |  |  |  | — |  |  |  | 6,688 |
U.S. government agency securities |  |  | — |  |  |  | 4,774 |  |  |  | — |  |  |  | 4,774 |
Equity securities: |  |  |  |  |  |  |  |  |  |  |  |
Mutual funds |  |  | 42,000 |  |  |  | — |  |  |  | — |  |  |  | 42,000 |
|  | $ | 666,744 |  |  | $ | 153,698 |  |  | $ | — |  |  | $ | 820,442 |
Derivative assets |  |  | — |  |  |  | 5,198 |  |  |  | — |  |  |  | 5,198 |
Total |  | $ | 666,744 |  |  | $ | 158,896 |  |  | $ | — |  |  | $ | 825,640 |
Liabilities |  |  |  |  |  |  |  |  |  |  |  |
Derivative liabilities |  | $ | — |  |  | $ | 1,128 |  |  | $ | — |  |  | $ | 1,128 |
Total |  | $ | — |  |  | $ | 1,128 |  |  | $ | — |  |  | $ | 1,128 |
Reported as follows: |  |  |  |  |  |  |  |  |  |  |  |
|  | (Level 1) |  |  | (Level 2) |  |  | (Level 3) |  |  | Total |
|  | (in thousands) |
Assets |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 616,508 |  |  | $ | 20,453 |  |  | $ | — |  |  | $ | 636,961 |
Marketable securities |  |  | — |  |  |  | 79,570 |  |  |  | — |  |  |  | 79,570 |
Long-term marketable securities |  |  | 50,236 |  |  |  | 53,675 |  |  |  | — |  |  |  | 103,911 |
Prepayments |  |  | — |  |  |  | 5,198 |  |  |  | — |  |  |  | 5,198 |
Total |  | $ | 666,744 |  |  | $ | 158,896 |  |  | $ | — |  |  | $ | 825,640 |
Liabilities |  |  |  |  |  |  |  |  |  |  |  |
Other current liabilities |  | $ | — |  |  | $ | 1,128 |  |  | $ | — |  |  | $ | 1,128 |
Total |  | $ | — |  |  | $ | 1,128 |  |  | $ | — |  |  | $ | 1,128 |
|  | December 31, 2022 |
|  | Quoted Prices in Active Markets for Identical Instruments (Level 1) |  |  | Significant Other Observable Inputs (Level 2) |  |  | Significant Unobservable Inputs (Level 3) |  |  | Total |
|  | (in thousands) |
Assets |  |  |  |  |  |  |  |  |  |  |  |
Cash |  | $ | 632,417 |  |  | $ | — |  |  | $ | — |  |  | $ | 632,417 |
Cash equivalents |  |  | 161,767 |  |  |  | 60,589 |  |  |  | — |  |  |  | 222,356 |
Available-for-sale securities: |  |  |  |  |  |  |  |  |  |  |  |
Corporate debt securities |  |  | — |  |  |  | 50,856 |  |  |  | — |  |  |  | 50,856 |
U.S. Treasury securities |  |  | — |  |  |  | 39,649 |  |  |  | — |  |  |  | 39,649 |
Commercial paper |  |  | — |  |  |  | 7,159 |  |  |  | — |  |  |  | 7,159 |
Debt mutual funds |  |  | 6,580 |  |  |  | — |  |  |  | — |  |  |  | 6,580 |
U.S. government agency securities |  |  | — |  |  |  | 6,352 |  |  |  | — |  |  |  | 6,352 |
Certificates of deposit and time deposits |  |  | — |  |  |  | 1,740 |  |  |  | — |  |  |  | 1,740 |
Non-U.S. government securities |  |  | — |  |  |  | 535 |  |  |  | — |  |  |  | 535 |
Equity securities: |  |  |  |  |  |  |  |  |  |  |  |
Mutual Funds |  |  | 37,518 |  |  |  | — |  |  |  | — |  |  |  | 37,518 |
|  | $ | 838,282 |  |  | $ | 166,880 |  |  | $ | — |  |  | $ | 1,005,162 |
Derivative assets |  |  | — |  |  |  | 86 |  |  |  | — |  |  |  | 86 |
Total |  | $ | 838,282 |  |  | $ | 166,966 |  |  | $ | — |  |  | $ | 1,005,248 |
Liabilities |  |  |  |  |  |  |  |  |  |  |  |
Derivative liabilities |  |  | — |  |  |  | 4,215 |  |  |  | — |  |  |  | 4,215 |
Total |  | $ | — |  |  | $ | 4,215 |  |  | $ | — |  |  | $ | 4,215 |
Reported as follows: |  |  |  |  |  |  |  |  |  |  |  |
|  | (Level 1) |  |  | (Level 2) |  |  | (Level 3) |  |  | Total |
|  | (in thousands) |
Assets |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 794,184 |  |  | $ | 60,589 |  |  | $ | — |  |  | $ | 854,773 |
Marketable securities |  |  | — |  |  |  | 39,612 |  |  |  | — |  |  |  | 39,612 |
Long-term marketable securities |  |  | 44,098 |  |  |  | 66,679 |  |  |  | — |  |  |  | 110,777 |
Prepayments |  |  | — |  |  |  | 86 |  |  |  | — |  |  |  | 86 |
Total |  | $ | 838,282 |  |  | $ | 166,966 |  |  | $ | — |  |  | $ | 1,005,248 |
Liabilities |  |  |  |  |  |  |  |  |  |  |  |
Other current liabilities |  | $ | — |  |  | $ | 4,215 |  |  | $ | — |  |  | $ | 4,215 |
Total |  | $ | — |  |  | $ | 4,215 |  |  | $ | — |  |  | $ | 4,215 |
The carrying amounts and fair values of Teradyne’s financial instruments at October 1, 2023 and December 31, 2022, were as follows:
|  | October 1, 2023 |  |  | December 31, 2022 |
|  | Carrying Value |  |  | Fair Value |  |  | Carrying Value |  |  | Fair Value |
|  | (in thousands) |
Assets |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 636,961 |  |  | $ | 636,961 |  |  | $ | 854,773 |  |  | $ | 854,773 |
Marketable securities |  |  | 183,481 |  |  |  | 183,481 |  |  |  | 150,389 |  |  |  | 150,389 |
Derivative assets |  |  | 5,198 |  |  |  | 5,198 |  |  |  | 86 |  |  |  | 86 |
Liabilities |  |  |  |  |  |  |  |  |  |  |  |
Derivative liabilities |  |  | 1,128 |  |  |  | 1,128 |  |  |  | 4,215 |  |  |  | 4,215 |
Convertible debt |  |  | 23,529 |  |  |  | 74,919 |  |  |  | 50,115 |  |  |  | 139,007 |
The fair values of accounts receivable, net and accounts payable approximate the carrying value due to the short-term nature of these instruments. The following table summarizes the composition of available-for-sale marketable securities at October 1, 2023:
|  | October 1, 2023 |
|  | Available-for-Sale |
|  | Cost |  |  | Unrealized Gain |  |  | Unrealized (Loss) |  |  | Fair Market Value |  |  | Fair Market Value of Investments with Unrealized Losses |
|  | (in thousands) |
U.S. Treasury securities |  | $ | 63,773 |  |  | $ | — |  |  | $ | (5,274 | ) |  | $ | 58,499 |  |  | $ | 57,794 |
Corporate debt securities |  |  | 57,710 |  |  |  | — |  |  |  | (6,880 | ) |  |  | 50,830 |  |  |  | 50,830 |
Commercial paper |  |  | 12,411 |  |  |  | 44 |  |  |  | (1 | ) |  |  | 12,454 |  |  |  | 2,988 |
Debt mutual funds |  |  | 8,724 |  |  |  | — |  |  |  | (488 | ) |  |  | 8,236 |  |  |  | 3,082 |
Certificates of deposit and time deposits |  |  | 6,688 |  |  |  | — |  |  |  | — |  |  |  | 6,688 |  |  |  | — |
U.S. government agency securities |  |  | 4,823 |  |  |  | — |  |  |  | (49 | ) |  |  | 4,774 |  |  |  | 4,774 |
|  | $ | 154,129 |  |  | $ | 44 |  |  | $ | (12,692 | ) |  | $ | 141,481 |  |  | $ | 119,468 |
Reported as follows:
|  | Cost |  |  | Unrealized Gain |  |  | Unrealized (Loss) |  |  | Fair Market Value |  |  | Fair Market Value of Investments with Unrealized Losses |
|  | (in thousands) |
Marketable securities |  | $ | 80,145 |  |  | $ | 44 |  |  | $ | (619 | ) |  | $ | 79,570 |  |  | $ | 62,711 |
Long-term marketable securities |  |  | 73,984 |  |  |  | — |  |  |  | (12,073 | ) |  |  | 61,911 |  |  |  | 56,757 |
|  | $ | 154,129 |  |  | $ | 44 |  |  | $ | (12,692 | ) |  | $ | 141,481 |  |  | $ | 119,468 |
The following table summarizes the composition of available-for-sale marketable securities at December 31, 2022:
|  | December 31, 2022 |
|  | Available-for-Sale |
|  | Cost |  |  | Unrealized Gain |  |  | Unrealized (Loss) |  |  | Fair Market Value |  |  | Fair Market Value of Investments with Unrealized Losses |
|  | (in thousands) |
Corporate debt securities |  | $ | 57,006 |  |  | $ | 3 |  |  | $ | (6,153 | ) |  | $ | 50,856 |  |  | $ | 50,667 |
U.S. Treasury securities |  |  | 44,030 |  |  |  | — |  |  |  | (4,381 | ) |  |  | 39,649 |  |  |  | 39,649 |
Commercial paper |  |  | 7,089 |  |  |  | 70 |  |  |  | — |  |  |  | 7,159 |  |  |  | — |
Debt mutual funds |  |  | 6,997 |  |  |  | — |  |  |  | (417 | ) |  |  | 6,580 |  |  |  | 3,095 |
U.S. government agency securities |  |  | 6,442 |  |  |  | — |  |  |  | (90 | ) |  |  | 6,352 |  |  |  | 6,352 |
Certificates of deposit and time deposits |  |  | 1,740 |  |  |  | — |  |  |  | — |  |  |  | 1,740 |  |  |  | — |
Non-U.S. government securities |  |  | 535 |  |  |  | — |  |  |  | — |  |  |  | 535 |  |  |  | — |
|  | $ | 123,839 |  |  | $ | 73 |  |  | $ | (11,041 | ) |  | $ | 112,871 |  |  | $ | 99,763 |
Reported as follows:
|  | Cost |  |  | Unrealized Gain |  |  | Unrealized (Loss) |  |  | Fair Market Value |  |  | Fair Market Value of Investments with Unrealized Losses |
|  | (in thousands) |
Marketable securities |  | $ | 39,950 |  |  | $ | 70 |  |  | $ | (408 | ) |  | $ | 39,612 |  |  | $ | 30,713 |
Long-term marketable securities |  |  | 83,889 |  |  |  | 3 |  |  |  | (10,633 | ) |  |  | 73,259 |  |  |  | 69,050 |
|  | $ | 123,839 |  |  | $ | 73 |  |  | $ | (11,041 | ) |  | $ | 112,871 |  |  | $ | 99,763 |
As of October 1, 2023, the fair market value of investments with unrealized losses less than one year and greater than one year totaled $54.3 million and $65.1 million, respectively. As of December 31, 2022, the fair market value of investments with unrealized losses for less than one year and greater than one year totaled $66.3 million and $33.4 million, respectively. Teradyne reviews its investments to identify and evaluate investments that have an indication of possible impairment. Based on this review, Teradyne determined that the unrealized losses related to these investments at October 1, 2023 and December 31, 2022 were not other than temporary. The contractual maturities of investments in available-for-sale securities held at October 1, 2023, were as follows:
|  | October 1, 2023 |
|  | Cost |  |  | Fair Market Value |
|  | (in thousands) |
Due within one year |  | $ | 80,145 |  |  | $ | 79,570 |
Due after 1 year through 5 years |  |  | 20,012 |  |  |  | 19,257 |
Due after 5 years through 10 years |  |  | 6,858 |  |  |  | 6,128 |
Due after 10 years |  |  | 38,390 |  |  |  | 28,290 |
Total |  | $ | 145,405 |  |  | $ | 133,245 |
Contractual maturities of investments in available-for-sale securities held at October 1, 2023, exclude debt mutual funds with a fair market value of $8.2 million, as they do not have a contractual maturity date. Derivatives Teradyne conducts business in various foreign countries, with certain transactions denominated in local currencies. As a result, Teradyne is exposed to risks relating to changes in foreign currency exchange rates. Teradyne’s foreign currency risk management objective is to minimize the effect of exchange rate fluctuations associated with the remeasurement of monetary assets and liabilities denominated in foreign currencies, and changes in its cash inflows attributable to the forecasted cash flows from certain foreign currency denominated revenues. To minimize the effect of exchange rate fluctuations associated with the remeasurement of monetary assets and liabilities denominated in foreign currencies, Teradyne enters into foreign currency forward contracts. The change in fair value of these derivatives is recorded directly in earnings and is used to offset the change in value of monetary assets and liabilities denominated in foreign currencies. Teradyne also enters into foreign currency forward and option contracts designated as cash flow hedges to hedge the risk of changes in its cash inflows attributable to changes in foreign currency exchange rates. The cash flow hedges have maturities of less than six months and mature in the period of revenue recognition for certain products and services in backlog and forecasted to be recognized in a future period. Teradyne evaluates cash flow hedges for effectiveness at inception based on the critical terms match method. The hedges are not expected to incur any ineffectiveness however a quarterly qualitative assessment of effectiveness is done to determine if the critical terms match method remains appropriate to use. The change in fair value of the contracts is recorded in accumulated other comprehensive income (loss) and reclassified to earnings at maturity date. Teradyne does not use derivative financial instruments for speculative purposes. At October 1, 2023 and December 31, 2022, Teradyne had the following contracts to buy and sell non-U.S. currencies for U.S. dollars and other non-U.S. currencies with the following notional amounts:
|  | Net Notional Value |
|  | October 1, 2023 |  |  | December 31, 2022 |
|  | (in millions) |
Currency Hedged (Buy/Sell) |  |  |  |  |  |
U.S. dollar/Japanese yen |  | $ | 49.6 |  |  | $ | 37.1 |
U.S. dollar/Taiwan dollar |  |  | 29.5 |  |  |  | 29.2 |
U.S. dollar/Korean won |  |  | 9.3 |  |  |  | 6.4 |
U.S. dollar/British pound sterling |  |  | 1.2 |  |  |  | 1.2 |
Euro/U.S. dollar |  |  | 22.7 |  |  |  | 38.4 |
Singapore dollar/U.S. dollar |  |  | 13.3 |  |  |  | 33.5 |
Philippine peso/U.S. dollar |  |  | 10.0 |  |  |  | 2.7 |
Chinese yuan/U.S. dollar |  |  | 1.3 |  |  |  | 2.2 |
Danish krone/U.S. dollar |  |  | 0.6 |  |  |  | — |
Total |  | $ | 137.5 |  |  | $ | 150.7 |
The fair value of the outstanding contracts was a net gain of $1.0 million and a net loss of $0.9 million, respectively, at October 1, 2023 and December 31, 2022. Unrealized gains and losses on foreign currency forward contracts and foreign currency remeasurement gains and losses on monetary assets and liabilities are included in other (income) expense, net. At October 1, 2023 and December 31, 2022, Teradyne had the following cash flow hedge contracts to buy and sell non-U.S. currencies for U.S. dollars with the following notional amounts:
|  | Net Notional Value |
|  | October 1, 2023 |  |  | December 31, 2022 |
|  | (in millions) |
Currency Hedged (Buy/Sell) |  |  |  |  |  |
U.S. dollar/Japanese yen |  | $ | 38.6 |  |  | $ | 61.2 |
U.S. dollar/Taiwan dollar |  |  | — |  |  |  | 10.9 |
Japanese yen/U.S. dollar |  |  | — |  |  |  | 23.4 |
Taiwan dollar/U.S. dollar |  |  | — |  |  |  | 5.5 |
Total |  | $ | 38.6 |  |  | $ | 101.0 |
The fair value of the outstanding cash flow hedge contracts was a gain of $3.0 million and a loss of $3.2 million at October 1, 2023 and December 31, 2022, respectively. Unrealized gains and losses on foreign currency cash flow hedge contracts are included in accumulated other comprehensive income (loss). At maturity, the gains or losses associated with cash flow hedge contracts are recorded to revenue. The following table summarizes the fair value of derivative instruments as of October 1, 2023 and December 31, 2022:
|  | Balance Sheet Location |  | October 1, 2023 |  |  | December 31, 2022 |
|  |  |  | (in thousands) |
Derivatives not designated as hedging instruments: |
Foreign exchange forward contracts |  | Prepayments |  | $ | 2,159 |  |  | $ | 86 |
Foreign exchange forward contracts |  | Other current liabilities |  |  | (1,128 | ) |  |  | (990 | )
Derivatives designated as hedging instruments: |
Foreign exchange option contracts |  | Prepayments |  |  | 3,039 |  |  |  | — |
Foreign exchange option contracts |  | Other current liabilities |  |  | — |  |  |  | (3,225 | )
Total derivatives |  |  |  | $ | 4,070 |  |  | $ | (4,129 | )
The following table summarizes the effect of derivative instruments recognized in the statement of operations for the three and nine months ended October 1, 2023 and October 2, 2022:
|  |  |  | For the Three Months Ended |  |  | For the Nine Months Ended |
|  | Location of (Gains) Losses Recognized in Statement of Operations |  | October 1, 2023 |  |  | October 2, 2022 |  |  | October 1, 2023 |  |  | October 2, 2022 |
|  |  |  | (in thousands) |
Derivatives not designated as hedging instruments: |
Foreign exchange forward contracts |  | Other (income) expense, net |  | $ | (1,886 | ) |  | $ | 1,246 |  |  | $ | (4,667 | ) |  | $ | (2,209 | )
Derivatives designated as hedging instruments: |
Foreign exchange option contracts |  | Revenue |  |  | (3,960 | ) |  |  | — |  |  |  | (2,008 | ) |  |  | — |
Total Derivatives |  |  |  | $ | (5,846 | ) |  | $ | 1,246 |  |  | $ | (6,675 | ) |  | $ | (2,209 | )
The table does not reflect the corresponding gains and losses from the remeasurement of the monetary assets and liabilities denominated in foreign currencies. For the three and nine months ended October 1, 2023, net losses from remeasurement of monetary assets and liabilities denominated in foreign currencies were $5.3 million and $12.3 million, respectively. For the three and nine months ended October 2, 2022, net losses from remeasurement of monetary assets and liabilities denominated in foreign currencies were $1.6 million and $9.5 million, respectively. See Note G: “Debt” regarding derivatives related to the convertible senior notes.

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration